DK1537113T3 - Arylalkylindoler med serotoninreceptoraffinitet anvendelige som terapeutiske midler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse - Google Patents

Arylalkylindoler med serotoninreceptoraffinitet anvendelige som terapeutiske midler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Info

Publication number: DK1537113T3
Authority: DK; Denmark
Prior art keywords: pharmaceutically acceptable; compositions containing; preparation; pharmaceutical compositions; therapeutic agents
Prior art date: 2002-06-21

Application number

DK03760859.3T

Other languages

English (en)

Other versions

DK1537113T5 (da

Inventor

Srinivasa Reddy Battula

Venkata Satya Veerabhadra Vadlamudi Rao

Venkateswarlu Jasti

Venkata Satya Nirogi Ramakrishna

Rama Sastri Kambhampati

Original Assignee

Suven Life Sciences Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-21

Filing date

2003-06-19

Publication date

2010-02-15

2003-06-19 Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd

2010-02-15 Publication of DK1537113T3 publication Critical patent/DK1537113T3/da

2011-01-10 Application granted granted Critical

2011-01-10 Publication of DK1537113T5 publication Critical patent/DK1537113T5/da

Links

-1 Arylalkyl indoles Chemical class 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
102000040125 5-hydroxytryptamine receptor family Human genes 0.000 title 1
108091032151 5-hydroxytryptamine receptor family Proteins 0.000 title 1
239000003814 drug Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
229940124597 therapeutic agent Drugs 0.000 title 1
239000000203 mixture Substances 0.000 abstract 4
150000001875 compounds Chemical class 0.000 abstract 3
239000000543 intermediate Substances 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
239000012453 solvate Substances 0.000 abstract 2
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Psychology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Addiction (AREA)
Reproductive Health (AREA)
Otolaryngology (AREA)
Obesity (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK03760859.3T 2002-06-21 2003-06-19 Arylalkylindoler med serotoninreceptoraffinitet anvendelige som terapeutiske midler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse DK1537113T5 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN476CH2002		2002-06-21
PCT/IN2003/000224 WO2004000845A1 (en)	2002-06-21	2003-06-19	Arylalkyl indoles having sertonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number	Publication Date
DK1537113T3 true DK1537113T3 (da)	2010-02-15
DK1537113T5 DK1537113T5 (da)	2011-01-10

Family

ID=29798511

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03760859.3T DK1537113T5 (da)	2002-06-21	2003-06-19	Arylalkylindoler med serotoninreceptoraffinitet anvendelige som terapeutiske midler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Country Status (16)

Country	Link
US (1)	US7297711B2 (da)
EP (1)	EP1537113B9 (da)
JP (1)	JP4455992B2 (da)
CN (1)	CN1662538A (da)
AT (1)	ATE444965T1 (da)
AU (1)	AU2003249584B9 (da)
BR (1)	BR0312175A (da)
CA (1)	CA2490115C (da)
DE (1)	DE60329607D1 (da)
DK (1)	DK1537113T5 (da)
ES (1)	ES2336664T3 (da)
MX (1)	MXPA04012834A (da)
NZ (1)	NZ537772A (da)
RU (1)	RU2320663C2 (da)
WO (1)	WO2004000845A1 (da)
ZA (1)	ZA200409888B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI1581538T1 (sl) *	2002-12-18	2007-08-31	Suven Life Sciences Ltd	Tetraciklični 3-substituirani indoli z afiniteto za receptor serotonina
PL1704154T3 (pl)	2004-01-02	2009-10-30	Suven Life Sciences Ltd	Nowe indeno[2,1a]indeny i izoindolo[2,1-a]indole
EP1937255A4 (en) *	2005-09-14	2013-06-26	Univ Witwatersrand Jhb	PHARMACEUTICAL COMPOSITION
JP4950490B2 (ja) *	2005-12-28	2012-06-13	株式会社東芝	不揮発性スイッチング素子およびその製造方法ならびに不揮発性スイッチング素子を有する集積回路
MX2011001062A (es) *	2008-07-30	2011-03-24	Ferrer Int	Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno.
CN110590748A (zh) *	2019-10-03	2019-12-20	黄泳华	芳香基氨基苄基哌嗪氮氧化物及其组合物与用途
CN115190815B (zh)	2019-12-26	2024-06-18	吉尔伽美什制药公司	芳基环己基胺衍生物及其在精神障碍的治疗中的用途
EP4084791B1 (en)	2020-02-18	2024-12-18	Gilgamesh Pharmaceuticals, Inc.	Specific tryptamines for use in the treatment of mood disorders
US12240813B2 (en)	2020-05-19	2025-03-04	Cybin Irl Limited	Deuterated tryptamine derivatives and methods of use
AU2021337466A1 (en)	2020-09-01	2023-03-30	Enveric Biosciences Canada Inc.	Halogenated psilocybin derivatives and methods of using
IL311211B1 (en)	2021-09-03	2026-02-01	Alexander Shulgin Res Institute Inc	Asymmetric allyl tryptamines
US12129234B1 (en)	2023-08-03	2024-10-29	Gilgamesh Pharmaceuticals, Inc.	Crystalline salts of N-ethyl-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine
US12180158B1 (en)	2023-08-03	2024-12-31	Gilgamesh Pharmaceuticals, Inc.	Crystalline fumarate salts of n-ethyl-2-(5-fluoro-1H-indol-3-yl)-n-methylethan-1-amine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA795239B (en)	1978-10-12	1980-11-26	Glaxo Group Ltd	Heterocyclic compounds
BE889931A (fr) *	1980-08-12	1982-02-11	Glaxo Group Ltd	Derives indoliques, leur preparation et leurs applications en tant que medicaments
GB8600397D0 (en) *	1986-01-08	1986-02-12	Glaxo Group Ltd	Chemical compounds
GB8719167D0 (en)	1987-08-13	1987-09-23	Glaxo Group Ltd	Chemical compounds
GB8724912D0 (en)	1987-10-23	1987-11-25	Wellcome Found	Indole derivatives
GB8819024D0 (en)	1988-08-10	1988-09-14	Glaxo Group Ltd	Chemical compounds
IL96891A0 (en)	1990-01-17	1992-03-29	Merck Sharp & Dohme	Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr)	1990-05-15	1991-11-16	Jacques Chauveau	Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
KR100215627B1 (ko)	1990-06-07	1999-08-16	레슬리 제인 에드워즈	치료용 헤테로사이클 화합물
SK278998B6 (sk)	1991-02-01	1998-05-06	Merck Sharp & Dohme Limited	Deriváty imidazolu, triazolu a tetrazolu, spôsob i
GB9113802D0 (en)	1991-06-26	1991-08-14	Smithkline Beecham Plc	Medicaments
US5206382A (en) *	1991-06-27	1993-04-27	Fidia Georgetown Institute For The Neurosciences	Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders
GB9210400D0 (en)	1992-05-15	1992-07-01	Merck Sharp & Dohme	Therapeutic agents
KR940007001A (ko)	1992-09-16	1994-04-26	최승주	새로운 n-신나모일-2-메틸-5-메톡시-3-인돌 아세트산 에스테르, 그 제조방법 및 이를 함유하는 약학적 제제
DK139593D0 (da) *	1993-12-16	1993-12-16	Lundbeck & Co As H	Compounds
FR2821843B1 (fr) *	2001-03-12	2003-05-09	Servier Lab	Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

2003
- 2003-06-19 RU RU2005101343/04A patent/RU2320663C2/ru not_active IP Right Cessation
- 2003-06-19 WO PCT/IN2003/000224 patent/WO2004000845A1/en not_active Ceased
- 2003-06-19 JP JP2004515420A patent/JP4455992B2/ja not_active Expired - Fee Related
- 2003-06-19 DK DK03760859.3T patent/DK1537113T5/da active
- 2003-06-19 MX MXPA04012834A patent/MXPA04012834A/es active IP Right Grant
- 2003-06-19 DE DE60329607T patent/DE60329607D1/de not_active Expired - Lifetime
- 2003-06-19 EP EP03760859A patent/EP1537113B9/en not_active Expired - Lifetime
- 2003-06-19 US US10/518,624 patent/US7297711B2/en not_active Expired - Lifetime
- 2003-06-19 CN CN038145979A patent/CN1662538A/zh active Pending
- 2003-06-19 AU AU2003249584A patent/AU2003249584B9/en not_active Ceased
- 2003-06-19 ES ES03760859T patent/ES2336664T3/es not_active Expired - Lifetime
- 2003-06-19 BR BR0312175-5A patent/BR0312175A/pt not_active IP Right Cessation
- 2003-06-19 AT AT03760859T patent/ATE444965T1/de active
- 2003-06-19 CA CA002490115A patent/CA2490115C/en not_active Expired - Fee Related
- 2003-06-19 NZ NZ537772A patent/NZ537772A/en not_active IP Right Cessation
2004
- 2004-12-07 ZA ZA200409888A patent/ZA200409888B/en unknown

Also Published As

Publication number	Publication date
JP2006501175A (ja)	2006-01-12
BR0312175A (pt)	2005-04-05
HK1074842A1 (en)	2005-11-25
RU2005101343A (ru)	2005-11-20
AU2003249584B9 (en)	2008-05-15
ZA200409888B (en)	2006-07-26
EP1537113A1 (en)	2005-06-08
US20050203103A1 (en)	2005-09-15
CA2490115C (en)	2009-09-01
US7297711B2 (en)	2007-11-20
CN1662538A (zh)	2005-08-31
ATE444965T1 (de)	2009-10-15
EP1537113B9 (en)	2010-05-26
AU2003249584B2 (en)	2007-10-25
CA2490115A1 (en)	2003-12-31
MXPA04012834A (es)	2005-04-25
DK1537113T5 (da)	2011-01-10
EP1537113B1 (en)	2009-10-07
AU2003249584A1 (en)	2004-01-06
NZ537772A (en)	2007-05-31
RU2320663C2 (ru)	2008-03-27
JP4455992B2 (ja)	2010-04-21
DE60329607D1 (de)	2009-11-19
ES2336664T3 (es)	2010-04-15
WO2004000845A1 (en)	2003-12-31

Publication	Publication Date	Title
WO2004048330A8 (en)	2005-10-27	N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
MXPA05011710A (es)	2006-01-23	Derivados de pirimidina con actividad de crf.
MY141559A (en)	2010-05-14	Triazole derivatives as tachykinin receptor antagonists
BR0315317A (pt)	2005-09-06	4-piperazinil benzenossulfonil indóis com afinidade para o receptor de 5-ht6
MXPA03011638A (es)	2004-04-02	Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
EA200700099A1 (ru)	2007-08-31	Производные пиридина
SE9904508D0 (sv)	1999-12-09	New compounds
EA200600811A1 (ru)	2006-10-27	НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
DK1523486T3 (da)	2008-03-03	Tetracykliske arylsulfonylindoler med serotoninreceptor-affinitet
GEP20094727B (en)	2009-07-10	Oxyindole derivatives as 5ht4 receptor agonists
DK1537113T5 (da)	2011-01-10	Arylalkylindoler med serotoninreceptoraffinitet anvendelige som terapeutiske midler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
NO20080670L (no)	2008-04-01	Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister
DE602004005960D1 (de)	2007-05-31	Heteroaryl-substituierte pyrrolä2, 3- büpyridin-derivate als crf-rezeptor-antagonisten
NO20040589L (no)	2004-03-19	Arylsulfonylderivater med 5-HT6 reseptor affinitet.
YU75101A (sh)	2005-07-19	Supstituisani biciklični heterocikli, postupak njihove izrade i njihova upotreba kao antigojaznih i hipoholesterolemijskih agenasa
NO20061981L (no)	2006-07-03	Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist
MXPA04005426A (es)	2004-10-11	Derivados de pirazol de anillos fuisionados.
TW200531694A (en)	2005-10-01	Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
DK1517909T3 (da)	2007-02-19	Tetracykliske arylcarbonylindoler med serotoninreceptor-affinitet til anvendelse som terpaeutiske midler, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende dem
NO20080671L (no)	2008-03-04	Bisykliske piperaziner som metabotrofiske glutamatreseptorantagonister
MXPA05011841A (es)	2006-01-26	Metil-indoles y metil-pirrolopiridinas como agonistas adrenergicos de alfa-1.
ECSP034870A (es)	2004-01-28	Nuevos derivados de indol con afinidad por el receptor 5-ht6
MY136600A (en)	2008-10-31	Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them